India Iron Deficiency Anemia Therapy Market to reach USD 0.24 billion by 2033, Growing at 3.90% CAGR

India Iron Deficiency Anemia Therapy Market Report Introduction

According to IMARC Group’s report titled "India Iron Deficiency Anemia Therapy Market Report, 2033" the report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.

Note : We are in the process of updating our reports to cover the 2026–2034 forecast period. For the most recent data, insights, and industry updates, please click on ‘Request Free Sample Report.

Request Free Sample Report : https://www.imarcgroup.com/india-iron-deficiency-anemia-therapy-market/requestsample

India Iron Deficiency Anemia Therapy Market Overview

The India iron deficiency anemia therapy market size reached USD 0.17 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 0.24 Billion by 2033, exhibiting a growth rate (CAGR) of 3.90% during 2025-2033. This growth is driven by increasing anemia prevalence among women and children, rising health awareness, government initiatives addressing nutritional deficiencies, advanced treatment options, and improved healthcare infrastructure and accessibility.

India Iron Deficiency Anemia Therapy Market Key Takeaways

• Current Market Size: USD 0.17 Billion in 2024
• CAGR: 3.90%
• Forecast Period: 2025-2033
• Rising demand for iron-fortified foods and novel bioavailability-enhancing formulations like microencapsulated iron and liposomal iron.
• Government initiatives such as Food Fortification Resource Centre (FFRC) mandating fortification of staple foods benefiting over 110 million people in 2023.
• High anemia prevalence with over 57% of Indian women aged 15-49 anemic as per NFHS-5 in 2023.
• Implementation of Anemia Mukt Bharat (AMB) initiative distributing over 230 million iron-folic acid doses in 2024, a rise of 18% from 2023.
• Increased AMB budget allocation by 15% from INR 950 crore in 2023 to INR 1,092 crore in 2024.
• Government target to reduce anemia prevalence among women of reproductive age to below 32% by 2025.

India Iron Deficiency Anemia Therapy Market Growth Factors

• Rising incidence of anemia among women and children is increasing demand for anemia diagnosis and treatment solutions in India.
• Growing public awareness of health and nutrition, supported by government-led initiatives, is driving higher uptake of anemia therapies.
• Government policies mandating fortification of staple foods with iron and other micronutrients are strengthening preventive and therapeutic demand.
• Introduction of advanced anemia treatments, including intravenous (IV) iron therapies such as Ferric Carboxymaltose, is expanding treatment adoption.
• Improvements in healthcare delivery infrastructure and increased accessibility to healthcare services in both rural and urban areas are supporting market growth.
• Development of new oral iron formulations with reduced gastrointestinal side effects is improving patient compliance and treatment adherence.
• Growth in both the pediatric and elderly populations is contributing to sustained demand for anemia therapies.
• Increasing use of iron supplements, IV therapies, and nutritional interventions delivered by healthcare workers across urban and rural regions is boosting market penetration.
• Enhanced government funding and support for programs such as Anemia Mukt Bharat is accelerating large-scale iron supplementation and awareness campaigns.

Buy The Latest Version Of the Reports with an Impressive Discount at: : https://www.imarcgroup.com/checkout?id=33180&method=1337

India Iron Deficiency Anemia Therapy Market Trends

• Rising adoption of iron-fortified foods is driven by increased emphasis on dietary interventions to address nutritional deficiencies.
• Introduction of innovative iron formulations with enhanced bioavailability—such as microencapsulated iron, liposome-based iron, and nano-iron—is improving treatment effectiveness.
• Iron fortification of staple foods, including rice and wheat flour, is being implemented through public distribution systems to improve population-level nutrition.
• The fortified food program represents a large-scale initiative, delivering an estimated USD 110 million in benefits to around 110 million recipients in 2023.
• Findings from the National Family Health Survey (NFHS) highlight a substantial anemia burden, prompting stronger policy action.
• The Government of India’s Anemia Mukt Bharat program is driving improvements in anemia management through weekly iron–folic acid supplementation, standardized treatment protocols, and behavior change communication.
• Expanded last-mile delivery of oral supplements and IV iron therapies via ASHA and Anganwadi workers has significantly improved treatment access.
• Innovations in anemia screening technologies, such as the AnemiaPhone, enable faster, more affordable identification of affected individuals and earlier intervention.
• Pharmaceutical manufacturers are developing next-generation iron therapies that enable rapid hemoglobin correction and iron store replenishment, with improved safety profiles compared to earlier treatments.

India Iron Deficiency Anemia Therapy Market Segmentation

Therapy Insights:

• Oral Iron Therapy: Widely used oral supplements for iron deficiency.
• Parenteral Iron Therapy: Intravenous and injectable iron treatments.
• Red Blood Cell Transfusion: Used in severe anemia cases.
• Others: Additional therapy modalities supporting anemia treatment.

Age Group Insights:

• Adults: Iron deficiency anemia treatment among the adult population.
• Pediatric: Therapy targeted at children with iron deficiency.
• Geriatric: Age-related anemia treatment for elderly populations.

End Use Insights:

• Clinics: Therapy administration in outpatient or clinic settings.
• Hospitals: Inpatient treatment and advanced care.
• Home Healthcare: Home-based anemia therapy and monitoring.

India Iron Deficiency Anemia Therapy Market Regional Insights

• North India
• South India
• East India
• West India

The market is dominated by North India with significant market share driven by higher healthcare infrastructure and accessibility, supported by a CAGR of 3.90% during the forecast period.

India Iron Deficiency Anemia Therapy Market Recent Developments & News

• December 2024: Cornell University researchers transferred AnemiaPhone technology for real-time iron deficiency screening to Indian Council of Medical Research (ICMR), enhancing national health program capabilities.
• March 2024: Cadila Pharmaceuticals launched Redshot Injection, an intravenous iron preparation for rapid hemoglobin correction in patients intolerant to oral supplements.
• February 2024: Emcure Pharmaceuticals initiated 'Unmask Anemia' campaign to raise awareness and promote early screening among women.

India Iron Deficiency Anemia Therapy Market Key Highlights of the Report

• Comprehensive quantitative analysis of market segments, historical and current trends, and forecasts from 2019 to 2033.
• Insights into market drivers, challenges, and opportunities.
• Porter’s Five Forces analysis to assess market attractiveness.
• Detailed competitive landscape and company evaluations.
• Segment-wise assessment by therapy, age group, end use, and region.
• 10-12 weeks post-sale analyst support and report customization options.

Get Your Customized Market Report Instantly: https://www.imarcgroup.com/request?type=report&id=33180&flag=E

Customization Note:

If you require any specific information not covered within this report’s scope, we will provide it as part of the customization.

About Us

IMARC Group is a global management consulting firm that helps ambitious changemakers create a lasting impact. The company offers comprehensive market assessment, feasibility studies, incorporation support, regulatory assistance, branding and strategy services, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel: (D) +91 120 433 0800

United States: +1-201971-6302